期刊文献+

链脲佐菌素诱导的糖尿病小鼠心肌组织中microRNA的表达 被引量:4

The expression changes of microRNA in the heart of streptozotocin-induced diabetic mice
原文传递
导出
摘要 目的观察STZ诱导的糖尿病模型小鼠心肌组织中microRNA(miRNA)的表达,对差异miRNA靶基因进行预测,为糖尿病心肌病的干预提供可选择的miRNA。方法建立T1DM小鼠模型,成模6周末,小鼠处死后留取并制备心肌组织标本用于形态学及分子生物学分析。采用RT2 miRNA PCR Arrays筛选差异表达的miRNA,并对差异miRNA靶基因进行生物信息学分析。结果成模6周末,组织学观察发现,模型组心肌细胞肥大明显,心肌肥大细胞分子标记B型尿钠肽(BNP)升高,组蛋白去乙酰化酶(Hdac1)降低(P<0.05)。基因芯片检测发现,模型组心肌组织中有13个差异表达的miRNA,其中miR-19a、miR-19b、miR-22、miR-503和miR-467e表达上调,miR-1、miR-29a、miR-30a、miR-96、miR-101a、miR-142-3p、miR-199-5p和miR-374表达下调。生物信息学分析发现,差异miRNA调控的靶基因与细胞增殖、凋亡、糖代谢和血管生成等生物学功能相关。结论 STZ诱导的糖尿病模型小鼠心肌组织miRNA表达谱发生改变,提示miRNA可能参与糖尿病心肌损伤过程。 Objective To investigate the microRNA (miRNA) differential expression profiles of heart in streptozotocin-induced diabetic mice and to find the potential target genes. Methods C57BL/6 mice were injected in peritoneal with STZ to estabish T1DiVL At the end of six weeks, the mice were sacrificed, the whole heart were collected for further analysis. The morphology of heart was detected using HE staining, the miRNA expression profile was detected by using RT2 miRNA PCR Arrays. The array was analyzed by bioinformatics for predicting the target genes. Results At the end of six weeks, histological observation showed that heart hypertrophy and the hypertrophy biomarker BNP were significantly higher in model group than in control group, but Hdacl significantly lower (P^0. 05). There were 13 miRNA differential expressions in model group detected by RTz miRNA PCR Arrays, including five up-regulated (miR-19a, miR-19b, miR-22, miR-503, miR-467e) and eight down-regulated (miR-1, miR-29a, miR-30a, miR-96, miR-101a, miR-142-3p, miR-199-5p, miR-374). These miRNAs participate in the regulation of cell proliferation, apoptosis, glycometabolism, and angiogenesis by the bioinformatics analysis. Conclusion Profiles of miRNA expression and bioinformatics analysis suggest miRNA plays an important role in the process of diabetic cardiomyopathy in STZ-induced diabetic mice.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2014年第3期255-258,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金资助项目(30971086) 黑龙江省卫生厅资助项目(2010-236) 黑龙江省普通高校组织损伤与修复重点实验室开放课题资助项目(zdsys2012-02)
关键词 MICRORNA (miRNA) 糖尿病 心肌损伤 mieroRNA (miRNA) ~ Diabetes mell^tus ~ Myocardial injury
  • 相关文献

参考文献10

  • 1Da Costa Martins PA, De Windt LJ. MicroRNAs in control ofcardiac hypertrophy. Cardiovasc Res,2012,93 : 563-572.
  • 2Papageorgiou N,Tousoulis D, Androulakis E,et al. The role ofmicroRNAs in cardiovascular disease. Curr Med Chem, 2012,19:2605-2610.
  • 3Fiedler J, Thum T. MicroRNAs in myocardial infarction. Arte-rioscler Thromb Vase Biol, 2013,33 : 201-205.
  • 4Sayed D,Hong C’Chen IY,et al. MicroRNAs play an essentialrole in the development of cardiac hypertrophy. Circ Res,2007,100:416-424.
  • 5刘洁婷,李洪志,吴丹,张春雷,袁哓环,赵冰海,金秀东,初彦辉.糖尿病心肌病与miR-1/miR-206和胰岛素样生长因子表达的关系[J].中国生化药物杂志,2012,33(4):389-391. 被引量:8
  • 6Xu XD.Song XW,Li Q,et al. Attenuation of microRNA-22 de-repressed PTEN to effectively protect rat cardiomyocytes fromhypertrophy. J Cell Physiol.2012,227: 1391-1398.
  • 7Duisters RF,Tijsen AJ, Schroen B, et al. miR-133 and miR-30regulate connective tissue growth factor: implications for a roleof microRNAs in myocardial matrix remodeling. Circ Res,2009,104:170-178.
  • 8Guo R, Hu N,Kandadi MR, et al. Facilitated ethanol metabo-lism promotes cardiomyocyte contractile dysfunction throughautophagy in murine hearts. Autophagy, 2012,8 : 593-608.
  • 9Pan W, Zhong Y, Cheng C, et al. MiR-30-regulated autophagymediates angiotensin U -induced myocardial hypertrophy. PLoS0ne,2013,8:e53950.
  • 10Pan Sun X, Shan H,'et al. MicroRNA-101 inhibited postin-farct cardiac fibrosis and improved left ventricular compliancevia the FBJ osteosarcoma oncogene/ transforming growth fac-toi^pl pathway. Circulation,2012,126:840-850.

二级参考文献8

  • 1Liu J. Control of protein synthesis and mRNA degradation by microRNAs[ J]. Curr Opin Cell Biol, 2008, 20:214-221.
  • 2Yu X Y,Song Y H, Geng Y J, et al. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1 [ J ]. Biochem Biophys Res Commun,2008,376:548-552.
  • 3Feng B, Chen S, Chiu J, et al. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level[ J]. Am J Physiol Endocrinol Metab ,2008,294 : 1119-1126.
  • 4Oka T, Komuro I. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure [ J ]. C irc J,2008,72 ( Suppl. A) :13-16.
  • 5Berry J M, Cao D J, Rothermel B A, et al. Histone deacetylase inhibition in the treatment of heart disease[ J]. Expert Opin Drug Saf, 2008,7( 1 ) :53-67.
  • 6Van Rooij E, Liu N. MicroRNAs flex their muscles [ J ]. Trends Genet ,2008,24 : 159-166.
  • 7Zhao Y, Ransom J F, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 [J]. Ce11,2007,129(2) :303-317.
  • 8Peng T, Zhang T, Lu X, et al. JNK1/c-fos inhibits cardiomyocyte TNF-alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxemia[ J]. Cardiovasc Res,2009,81:733-741.

共引文献7

同被引文献30

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部